Article Text

Download PDFPDF

Extent and determinants of catastrophic health expenditure for tuberculosis care in Chongqing municipality, China: a cross-sectional study
  1. Weixia Duan1,2,
  2. Wen Zhang1,
  3. Chengguo Wu1,
  4. Qingya Wang1,
  5. Ya Yu1,
  6. Hui Lin3,
  7. Ying Liu1,
  8. Daiyu Hu1
  1. 1 Department of Prevention, Chongqing Institute of Tuberculosis Prevention and Treatment, Chongqing, China
  2. 2 The center of Laboratory Medicine, Chongqing Occupational Diseases Prevention Hospital, Chongqing, China
  3. 3 Department of Epidemiology, The Third Military Medical University, Chongqing, China
  1. Correspondence to Professor Ying Liu; 910981960{at}qq.com and Professor Daiyu Hu; hukaixiou{at}263.net

Abstract

Objective To investigate the extent and associations of patient/diagnostic delay and other potential factors with catastrophic health expenditure (CHE) for tuberculosis (TB) care in Chongqing municipality, China.

Design A cross-sectional study.

Setting Four counties of Chongqing municipality, China.

Participants A total of 1199 patients with active pulmonary TB beyond 16 years and without mental disorders were consecutively recruited in the four counties’ designated TB medical institutions.

Outcome measures The incidence and intensity of CHE for TB care were described. The association between patients’ ‘sociodemographic and clinical characteristics such as patient delay, diagnostic delay, forms of TB, health insurance status and hospitalisation and CHE were analysed using univariate and multivariate logistic regression.

Results The incidence of CHE was 52.8% and out-of-pocket (OOP) payments were 93% of the total costs for TB care. Compared with patients without delay, the incidence and intensity of CHE were higher in patients who had patient delay or diagnostic delay. Patients who experienced patient delay or diagnostic delay, who was a male, elderly (≥60 years), an inhabitant, a peasant, divorced/widow, the New Cooperative Medical Scheme membership had greater risks of incurring CHE for TB care. Having a higher educational level appeared to be a protective factor. However, hospitalisation was not associated with CHE after controlling for other variables.

Conclusion The incidence and intensity of CHE for TB care are high, which provides baseline data about catastrophic costs that TB-related households faced in Chongqing of China. Variety of determinants of CHE implicate that it is essential to take effective measures to promote early seeking care and early diagnosis, improve the actual reimbursement rates of health insurance, especially for outpatients, and need more fine-tuned interventions such as precise poverty alleviation to reduce catastrophic costs of the vulnerable population.

  • tuberculosis
  • catastrophic health expenditure
  • patient delay
  • diagnostic delay
  • health insurance

This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Contributors DH: designed the study and drafted the manuscript. YL: designed the study, implemented the survey and analysed the data. WD: designed the study, analysed the data and drafted the manuscript. WZ, CW, QW and YY: implemented the survey and collected data. HL: analysed the data and drafted the manuscript. All authors read and approved the final version of the manuscript.

  • Funding This work was supported by the research funding from Chongqing Municipal Health Bureau (No 2012-1-087, 2017MSXM124 and 2017MSXM125).

  • Competing interests None declared.

  • Ethics approval The study was approved by the Ethical Committee of Chongqing Institute of Tuberculosis Prevention and Treatment, Chongqing, China.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Data sharing statement No additional data are available.

  • Patient consent for publication Obtained.